Tissue Regenix Group PLC operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tissue Regenix Group PLC with three other
miscellaneous service companies in Europe:
Eurocine Vaccines AB
sales of 550,000.00 Swedish Kronor [US$66,280.50 ]
(£3,967.00 [US$6,001.52 ]
Reneuron Group PLC
(£22,000.00 [US$33,282.92 ]
of which 100%
was Cell-Based Therapies).